NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 36, 2013, Pages 14676-14681

  Sohn, Yang Sung ^a   Tamir, Sagi ^a   Song, Luhua ^b   Michaeli, Dorit ^a   Matouk, Imad ^a,c   Conlan, Andrea R ^d   Harir, Yael ^a   Holt, Sarah H ^b   Shulaev, Vladimir ^b   Paddock, Mark L ^d   Hochberg, Abraham ^a   Cabanchick, Ioav Z ^a   Onuchic, José N ^e   Jennings, Patricia A ^d   Nechushtai, Rachel ^a   Mittler, Ron ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c AL QUDS UNIVERSITY   (Palestine)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RICE UNIVERSITY   (United States)

Author keywords

Cisd1; Cisd2; MCF7; MDA MB 231; Miner1

Indexed keywords

IRON; MITONEET PROTEIN; NAF 1 PROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CISD1 PROTEIN, HUMAN; ERIS PROTEIN, HUMAN; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; OLIGOMYCIN; PIOGLITAZONE;

ARTICLE; AUTOPHAGY; BREAST CANCER; BREAST CELL; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; HOMEOSTASIS; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BREAST TUMOR; CARCINOGENESIS; CELL SURVIVAL; DRUG EFFECTS; FEMALE; GENETICS; GLYCOLYSIS; IMMUNOBLOTTING; MCF 7 CELL LINE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; TUMOR VOLUME; ULTRASTRUCTURE; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GLYCOLYSIS; HOMEOSTASIS; HUMANS; IMMUNOBLOTTING; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OLIGOMYCINS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; THIAZOLIDINEDIONES; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84883402935     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1313198110     Document Type: Article

References (31)

1. Tait SW, Green DR (2010) Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11(9):621-632.
2. Zhang Y, Yang JM (2013) Altered energy metabolism in cancer: A unique opportunity for therapeutic intervention. Cancer Biol Ther 14(2):81-89.
3. Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12(10):685-698.
4. Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491(7424):364-373.
5. Shoshan-Barmatz V, Mizrachi D (2012) VDAC1: From structure to cancer therapy. Front Oncol 2:164.
6. Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9(6):447-464.
7. Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13(5):342-355.
8. Wiley SE, Murphy AN, Ross SA, van der Geer P, Dixon JE (2007) MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc Natl Acad Sci USA 104(13):5318-5323. (Pubitemid 47175678)
9. Lin J, Zhang L, Lai S, Ye K (2011) Structure and molecular evolution of CDGSH iron-sulfur domains. PLoS ONE 6(9):e24790.
10. Conlan AR, et al. (2009) Crystal structure of Miner1: The redox-active 2Fe-2S protein causative in Wolfram syndrome 2. J Mol Biol 392(1):143-153.
11. Paddock ML, et al. (2007) MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc Natl Acad Sci USA 104(36):14342-14347. (Pubitemid 350003263)
12. Chang NC, Nguyen M, Shore GC (2012) BCL2-CISD2: An ER complex at the nexus of autophagy and calcium homeostasis? Autophagy 8(5):856-857.
13. Chang NC, Nguyen M, Germain M, Shore GC (2010) Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1. EMBO J 29(3):606-618.
14. Kusminski CM, et al. (2012) MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 18(10):1539-1549.
15. Nechushtai R, et al. (2012) Characterization of Arabidopsis NEET reveals an ancient role for NEET proteins in iron metabolism. Plant Cell 24(5):2139-2154.
16. Wu CY, et al. (2012) A persistent level of Cisd2 extends healthy lifespan and delays aging in mice. Hum Mol Genet 21(18):3956-3968.
17. Taminelli GL, et al. (2008) CISD1 codifies a mitochondrial protein upregulated by the CFTR channel. Biochem Biophys Res Commun 365(4):856-862. (Pubitemid 350245381)
18. Zuris JA, et al. (2011) Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proc Natl Acad Sci USA 108(32):13047-13052.
19. Chen YF, Wu CY, Kirby R, Kao CH, Tsai TF (2010) A role for the CISD2 gene in lifespan control and human disease. Ann N Y Acad Sci 1201:58-64.
20. Chen YF, et al. (2009) Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev 23(10):1183-1194.
21. Chang NC, et al. (2012) Bcl-2-associated autophagy regulator Naf-1 required for maintenance of skeletal muscle. Hum Mol Genet 21(10):2277-2287.
22. 2+ homeostasis. EMBO Mol Med 5(6):904-918.
23. Salem AF, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP (2012) Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance. Cell Cycle 11(22):4174-4180.
24. Stelzer G, et al. (2011) In silico human genomics with GeneCards. Hum Genom 5(6):709-717.
25. Cortes DF, et al. (2011) Differential gene expression in normal and transformed human mammary epithelial cells in response to oxidative stress. Free Radic Biol Med 50(11):1565-1574.
26. Kongara S, Karantza V (2012) The interplay between autophagy and ROS in tumorigenesis. Front Oncol 2:171.
27. Dormandy J, Bhattacharya M, van Troostenburg de Bruyn AR; PROactive investigators (2009) Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: An overview of data from PROactive. Drug Saf 32(3):187-202.
28. Li MY, et al. (2012) Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice. Curr Cancer Drug Targets 12(6):597-606.
29. Bosetti C, et al. (2013) Cancer risk for patients using thiazolidinediones for type 2 diabetes: A meta-analysis. Oncologist 18(2):148-156.
30. Anastasiou D (2013) Metformin: A case of divide and conquer. Breast Cancer Res 15(2):306.
31. Sohn YS, Mitterstiller AM, Breuer W, Weiss G, Cabantchik ZI (2011) Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal. Br J Pharmacol 164(2b):406-418.